FCRP logo

FCRP Home FCRP Links Contact us MSU home BCOG navigation bar

Grant Abstract


Automated Telephone Monitoring for Symptom Management Supplement
(Grant #NCI R01 CA030724)

Automated Telephone Monitoring for Symptom ManagementSupplementThe proposed supplement seeks to build on existing work by this team and by other researchers to measure the impact of symptoms among cancer patients undergoing chemotherapy. Timely assessment and management of symptoms is key to successful treatment, maintaining physical and social functioning, and to reducing emotional distress of the patients. Before symptoms can be managed effectively, it is necessary to have reliable and valid instruments for their measurement. The current grant (R01 CA030724-01) proposed testing the effect of a behavioral intervention using a linear combination of reported severity for seven core symptoms. The symptoms were selected based on their prevalence in past research conducted by this team. In implementing this research, we have extended our list to include the original 15 symptoms that have been used in our past work. The index of symptom severity used in the original grant is the sum of reported severities of 7 core symptoms, with zero used to take into account the absence of a symptom. In the past research completed by the investigator, the raw index equal to the sum of severities of 15 symptoms was also used.In the proposed research, we will employ a number of data sets from randomized clinical trials administered to patients with solid tumors who are undergoing chemotherapy, including data from the two trials currently being completed, R01 CA030724 and R01 CA79280. An optimized symptom severity index will be developed using item response theory approach. We evaluate the reliability and stability of this measure across different samples of cancer patients undergoing chemotherapy. By comparing optimized index of symptom severity to the existing raw indices, this work will evaluate the relative benefits of fewer numbers of symptoms in the construction and the subsequent testing of this measure across the samples. The effect of using different symptom severity indices on findings related to testing the impact of a cognitive-behavioral intervention on symptom severity, which is the common primary outcome to be tested in these trials.

PERFORMANCE SITE(S) (organization, city, state)

Michigan State University, East Lansing, MI


KEY PERSONNEL.

Name Organization Role on Project
Given, Charles W., PhD Michigan State University Principal Investigator
Rahbar, Mohammad Hossein, PhD Michigan State University Co-Investigator
Gardiner, Joseph, PhD Michigan State University Co-Investigator
Sikorskii, Alla, PhD Michigan State University Co-Investigator
Chang, Chih-Hung, PhD Northwestern University Consultant


MSU is an affirmative-action, equal-opportunity institution.
Copyright © 2000 by Michigan State University Board of Trustees.
If you have questions or comments please contact the WEBMASTER
Last modified on 04/19/2004